Author

S. Wuchty

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Augspach· 1 shared A. C. Diaz· 1 shared A. D. Pellegrini· 1 shared A. M. Cirrincione· 1 shared B. J. Harrison· 1 shared C. A. Reimonn· 1 shared C. Howell· 1 shared D. Clarke· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Augspach

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Epidermal Eg5 promotes X-ROS dependent paclitaxel neurotoxicity

A. C. Diaz, A. M. Cirrincione, N. A. Schmidt, M. J. Ugo, M. C. A. Sanchez, C. A. Reimonn, S. Wuchty, A. D. Pellegrini, L. R. Rude, L. G. Pappalardo, D. P. Regan, C. Howell, S. Hrstka, S. Dasari, T. S. Lisse, , S. Rieger

The paper shows paclitaxel induces microtubule modifications in keratinocytes, leading to neurotoxicity via X-ROS and MMP-13, with Eg5 playing a key role.

bioRxiv · May 22, 2023 · PreprintCell Biology

Minor intron splicing efficiency increases with the development of lethal prostate cancer

A. Augspach, K. Drake, L. Roma, E. Qian, S. R. Lee, D. Clarke, S. Kumar, M. Jaquet, J. Gallon, M. Bolis, J. Triscott, J. A. Galvan, Y. Chen, G. Thalmann, M. Kruithof-de Julio, , M. A. Rubin

The paper shows that minor intron splicing efficiency increases in castration-resistant prostate cancer and that inhibiting the minor spliceosome reduces tumor burden.

bioRxiv · Dec 9, 2021 · PreprintCancer Biology